CISATRACURIUM ACCORDPHARMA 2 mg/ml, solution for injection/for infusion 5 bottles of 5 ml
Active ingredients: BÉSILATE DE CISATRACURIUM, CISATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion5 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CISATRACURIUM ACCORDPHARMA 2 mg/mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacons en verre de 5 mL
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 May 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62067536CIP75507234CIP133400955072348Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CISATRACURIUMsolution | 2 mg · 1 ml de solution | FT |
| BÉSILATE DE CISATRACURIUMsolution | 2,68 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BESILATE DE CISATRACURIUM équivalant à CISATRACURIUM 2 mg/ml - NIMBEX 2 mg/ml, solution injectable/pour perfusion